Authors: Hughes, ODM Perkins, AC Frier, M Wastie, ML Denton, G Price, MR Denley, H Bishop, MC

Citation: Odm. Hughes et al., Imaging for staging bladder cancer: a clinical study of (111)indium-labelled anti-MUC1 mucin intravenous monoclonal antibody C595, BJU INT, 87(1), 2001, pp. 39-46

Authors: Hughes, ODM Bishop, MC Perkins, AC Wastie, ML Denton, G Price, MR Frier, M Denley, H Rutherford, R Schubiger, PA

Citation: Odm. Hughes et al., Targeting superficial bladder cancer by the intravesical administration ofcopper-67-labeled anti-MUC1 mucin monoclonal antibody C595, J CL ONCOL, 18(2), 2000, pp. 363-370

Authors: Simms, MS Hughes, ODM Limb, M Price, MR Bishop, MC

Citation: Ms. Simms et al., MUC1 mucin as a tumour marker in bladder cancer, BJU INT, 84(3), 1999, pp. 350-352

Authors: Denton, G Brady, K Lo, BKC Murray, A Graves, CRL Hughes, ODM Tendler, SJB Laughton, CA Price, MR

Citation: G. Denton et al., Production and characterization of an anti-(MUC1 mucin) recombinant diabody, CANCER IMMU, 48(1), 1999, pp. 29-38